Adverse Drug Reactions of Different Brands of Ceftazidime Injection
|ClinicalTrials.gov Identifier: NCT00173901|
Recruitment Status : Unknown
Verified January 2001 by National Taiwan University Hospital.
Recruitment status was: Active, not recruiting
First Posted : September 15, 2005
Last Update Posted : September 15, 2005
|Condition or disease||Intervention/treatment||Phase|
|Infection||Drug: ceftazidime||Phase 4|
Ceftazidime is a third generation cephalosporins that should be reserved for severe bacterial infections. Substitution of the brand ceftazidime with a generic ceftazidime raised some concerns.
The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||536 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Adverse Drug Reactions of Different Brands of Ceftazidime Injection|
|Study Start Date :||March 2001|
|Estimated Study Completion Date :||April 2002|
- The adverse drug reactions of ceftazidime
- The effectiveness of ceftazidime
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00173901
|National Taiwan University Hospital|
|Taipei, Taiwan, 100|
|Study Chair:||Shan-Chwen Chang, MD PhD||National Taiwan University Hospital|